Frontiers in Oncology | Hematologic Malignancies

Brief Research Report

Published on 08 Aug 2022

Presence of the GFI1-36N single nucleotide polymorphism enhances the response of MLL-AF9 leukemic cells to CDK4/6 inhibition

in Hematologic Malignancies

Jan Vorwerk
Kaiyan Sun
Daria Frank
Felix Neumann
Jana Hüve
Paulina Marie Budde
Longlong Liu
Xiaoqing Xie
Pradeep Kumar Patnana
Helal Mohammed Mohammed Ahmed

Frontiers in Oncology

doi 10.3389/fonc.2022.903691

4,927 views
2 citations

Original Research

Published on 05 Aug 2022

Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors

in Hematologic Malignancies

Manuela Mancini
Sara De Santis
Cecilia Monaldi
Fausto Castagnetti
Annalisa Lonetti
Samantha Bruno
Elisa Dan
Barbara Sinigaglia
Gianantonio Rosti
Michele Cavo

Frontiers in Oncology

doi 10.3389/fonc.2022.901132

3,914 views
7 citations

Brief Research Report

Published on 05 Aug 2022

Tumor-specific T cell-mediated upregulation of PD-L1 in myelodysplastic syndrome cells does not affect T-cell killing

in Hematologic Malignancies

Valentina Ferrari
Alison Tarke
Hannah Fields
Tiffany N. Tanaka
Stephen Searles
Maurizio Zanetti

Frontiers in Oncology

doi 10.3389/fonc.2022.915629

2,787 views
3 citations

Review

Published on 05 Aug 2022

Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders

in Hematologic Malignancies

Argiris Symeonidis
Spiros Chondropoulos
Evgenia Verigou
Vasileios Lazaris
Alexandra Kourakli
Panagiotis Tsirigotis

Frontiers in Oncology

doi 10.3389/fonc.2022.884723

6,889 views
8 citations

Case Report

Published on 05 Aug 2022

Case Report: A rare case of small bowel obstruction secondary to plasma cell myeloma

in Hematologic Malignancies

Arturo Bonometti
Nicola Aronico
Giovanni Santacroce
Sara Fraticelli
Marco Lucioni
Claudio Salvatore Cartia
Alessandro Vanoli
Mario Andrea Latorre
Luca Arcaini
Marco Paulli

Frontiers in Oncology

doi 10.3389/fonc.2022.934566

2,982 views
1 citation

Original Research

Published on 05 Aug 2022

Long-term treatment outcome of Castleman’s disease: A real-world experience

in Hematologic Malignancies

Gi-June Min
Young-Woo Jeon
Tong Yoon Kim
Dae Hun Kwag
Jong Hyuk Lee
Joon Yeop Lee
Sung-Soo Park
Silvia Park
Jae-Ho Yoon
Sung-Eun Lee

Frontiers in Oncology

doi 10.3389/fonc.2022.974770

7,130 views
6 citations

Original Research

Published on 05 Aug 2022

Novel myeloma patient-derived xenograft models unveil the potency of anlotinib to overcome bortezomib resistance

in Hematologic Malignancies

Yanhua Yue
Yang Cao
Xunyuan Mao
Fei Wang
Peng Fan
Long Qian
Shuxin Guo
Feng Li
Yanting Guo
Tongbing Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.894279

6,282 views
6 citations

Systematic Review

Published on 05 Aug 2022

Efficacy and safety profile of COVID-19 mRNA vaccine in patients with hematological malignancies: Systematic review and meta-analysis

in Hematologic Malignancies

Ikhwan Rinaldi
Samuel Pratama
Lowilius Wiyono
Jeremy Rafael Tandaju
Indy Larasati Wardhana
Kevin Winston

Frontiers in Oncology

doi 10.3389/fonc.2022.951215

7,655 views
20 citations

Brief Research Report

Published on 05 Aug 2022

PD-1 and LAG-3 expression in EBV-associated pediatric Hodgkin lymphoma has influence on survival

in Hematologic Malignancies

Oscar Jimenez
Tamara Mangiaterra
Sandra Colli
Mercedes García Lombardi
Maria Victoria Preciado
Elena De Matteo
Paola Chabay

Frontiers in Oncology

doi 10.3389/fonc.2022.957208

3,284 views
11 citations

Original Research

Published on 05 Aug 2022

Azacitidine and donor lymphocyte infusion for patients with relapsed acute myeloid leukemia and myelodysplastic syndromes after allogeneic hematopoietic stem cell transplantation: A meta-analysis

in Hematologic Malignancies

Xuefeng Li
Wen Wang
Xin Zhang
Yu Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.949534

5,552 views
11 citations

Case Report

Published on 03 Aug 2022

Case Report: TEMPI syndrome: Report of three cases and treatment follow-up

in Hematologic Malignancies

Zhuo-Fan Xu
Jing Ruan
Long Chang
Sijin Wu
Jinkai Lin
Wei Wang
XinXin Cao
Lu Zhang
Jian Li
Daobin Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.949647

5,340 views
3 citations

Original Research

Published on 03 Aug 2022

Associations of clinical and circulating metabolic biomarkers with low physical fitness and function in adults with chronic lymphocytic leukemia

in Hematologic Malignancies

Andrea Sitlinger
Michael A. Deal
Erwin Garcia
Margery Connelly
Dana Thompson
Tiffany Stewart
Grace Macdonald
Erik D. Hanson
Megan Neely
Ben Neely

Frontiers in Oncology

doi 10.3389/fonc.2022.933619

4,790 views
4 citations

Brief Research Report

Published on 03 Aug 2022

The role of adjuvant chemotherapy in the management of acute promyelocytic leukemia differentiation syndrome

in Hematologic Malignancies

Dominic LaBella
Samuel Regan
Heiko Konig
Daniel N. Egan
Neil A. Bailey
Raya Mawad
Morgan Gilbert
John M. Pagel
Jeffrey J. Pu

Frontiers in Oncology

doi 10.3389/fonc.2022.911745

3,319 views
3 citations

Original Research

Published on 02 Aug 2022

Clinicopathologic study of mantle cell lymphoma with epstein-barr virus infection: A case series and literature review

in Hematologic Malignancies

Xiaoju Li
Fanlin Zhou
Shijie Li
Yangyang Wang
Jianing Fan
Xiao Liang
Yan Peng
Yudi Jin
Weiyang Jiang
Fang Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.933964

3,011 views
2 citations

Original Research

Published on 02 Aug 2022

iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma

in Hematologic Malignancies

Qinhua Liu
Guanrong Dai
Yi Wu
Mingxia Zhang
Mingya Yang
Xiaonan Wang
Mingyue Song
Xiaodan Li
Ruixiang Xia
Zhengsheng Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.822805

7,193 views
38 citations

Mini Review

Published on 02 Aug 2022

Exploring the current molecular landscape and management of multiple myeloma patients with the t(11;14) translocation

in Hematologic Malignancies

Michael D. Diamantidis
Sofia Papadaki
Evdoxia Hatjiharissi

Frontiers in Oncology

doi 10.3389/fonc.2022.934008

7,958 views
24 citations

Original Research

Published on 28 Jul 2022

Prediction of prognosis and pathologic grade in follicular lymphoma using 18F-FDG PET/CT

in Hematologic Malignancies

Hongyan Li
Min Wang
Yajing Zhang
Fan Hu
Kun Wang
Chenyang Wang
Zairong Gao

Frontiers in Oncology

doi 10.3389/fonc.2022.943151

6,186 views
27 citations

Case Report

Published on 28 Jul 2022

Case report and literature review: Hemophagocytic lymphohistiocytosis in a pregnant woman with systemic lupus erythematosus with Syntaxin 11 gene defect

in Hematologic Malignancies

Wei Ren
Siyuan Yang
Haiying Liu
Zhenglun Pan
Zhao Li
Peng Qiao
Hui Ma

Frontiers in Oncology

doi 10.3389/fonc.2022.937494

3,300 views
4 citations

Original Research

Published on 26 Jul 2022

18F-FDG PET/CT Plays a Limited Role in Replacing Bone Marrow Biopsy for Newly Diagnosed Advanced-Stage Patients With Extranodal Natural Killer/T-Cell Lymphoma

in Hematologic Malignancies

Chunli Yang
Wanchun Wu
Huijie Zhou
Sha Zhao
Rong Tian
Maya Xiang
Liqun Zou

Frontiers in Oncology

doi 10.3389/fonc.2022.894804

2,398 views
11 citations

Case Report

Published on 25 Jul 2022

Case report: Zanubrutinib-induced dermatological toxicities: A single-center experience and review

in Hematologic Malignancies

Lingling Wang
Jiao Tang
Jun Feng
Yongfen Huang
Yuexin Cheng
Hao Xu
Yuqing Miao

Frontiers in Oncology

doi 10.3389/fonc.2022.941633

13,147 views
10 citations

Editorial

Published on 19 Jul 2022

Editorial: Real World Outcomes of Lymphoma From India

in Hematologic Malignancies

Lalit Kumar
Naresh KN
Sumeet Gujral
Padmaj Kulkarni
Martin R. Stockler
Reena Nair

Frontiers in Oncology

doi 10.3389/fonc.2022.922370

7,043 views
6 citations

Original Research

Published on 19 Jul 2022

Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma

in Hematologic Malignancies

Junxiang Gu
Tingting Jiang
Shixue Liu
Bo Ping
Ruiwen Li
Wenwen Chen
Ling Wang
Xin Huang
Gezhi Xu
Qing Chang

Frontiers in Oncology

doi 10.3389/fonc.2022.932674

4,666 views
17 citations

Brief Research Report

Published on 19 Jul 2022

The Role of Clonal Evolution on Progression, Blood Parameters, and Response to Therapy in Multiple Myeloma

in Hematologic Malignancies

Sarah Sandmann
Katharina Karsch
Peter Bartel
Rita Exeler
Tobias J. Brix
Elias K. Mai
Julian Varghese
Georg Lenz
Cyrus Khandanpour

Frontiers in Oncology

doi 10.3389/fonc.2022.919278

3,323 views
6 citations

Original Research

Published on 18 Jul 2022

Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials

in Hematologic Malignancies

Fortunato Morabito
Elena Zamagni
Concetta Conticello
Vincenzo Pavone
Salvatore Palmieri
Sara Bringhen
Monica Galli
Silvia Mangiacavalli
Daniele Derudas
Elena Rossi

Frontiers in Oncology

doi 10.3389/fonc.2022.890376

4,593 views
4 citations

2,058 articles

articles

Presence of the GFI1-36N single nucleotide polymorphism enhances the response of MLL-AF9 leukemic cells to CDK4/6 inhibition

Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors

Tumor-specific T cell-mediated upregulation of PD-L1 in myelodysplastic syndrome cells does not affect T-cell killing

Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders

Case Report: A rare case of small bowel obstruction secondary to plasma cell myeloma

Long-term treatment outcome of Castleman’s disease: A real-world experience

Novel myeloma patient-derived xenograft models unveil the potency of anlotinib to overcome bortezomib resistance

Efficacy and safety profile of COVID-19 mRNA vaccine in patients with hematological malignancies: Systematic review and meta-analysis

PD-1 and LAG-3 expression in EBV-associated pediatric Hodgkin lymphoma has influence on survival

Azacitidine and donor lymphocyte infusion for patients with relapsed acute myeloid leukemia and myelodysplastic syndromes after allogeneic hematopoietic stem cell transplantation: A meta-analysis

Case Report: TEMPI syndrome: Report of three cases and treatment follow-up

Associations of clinical and circulating metabolic biomarkers with low physical fitness and function in adults with chronic lymphocytic leukemia

The role of adjuvant chemotherapy in the management of acute promyelocytic leukemia differentiation syndrome

Clinicopathologic study of mantle cell lymphoma with epstein-barr virus infection: A case series and literature review

iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma

Exploring the current molecular landscape and management of multiple myeloma patients with the t(11;14) translocation

Prediction of prognosis and pathologic grade in follicular lymphoma using 18F-FDG PET/CT

Case report and literature review: Hemophagocytic lymphohistiocytosis in a pregnant woman with systemic lupus erythematosus with Syntaxin 11 gene defect

18F-FDG PET/CT Plays a Limited Role in Replacing Bone Marrow Biopsy for Newly Diagnosed Advanced-Stage Patients With Extranodal Natural Killer/T-Cell Lymphoma

Case report: Zanubrutinib-induced dermatological toxicities: A single-center experience and review

Editorial: Real World Outcomes of Lymphoma From India

Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma

The Role of Clonal Evolution on Progression, Blood Parameters, and Response to Therapy in Multiple Myeloma

Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials